GE to distribute imaging device of DeepBreeze
The firms launched the VRIICU in Europe today, and plan launches in Asia and the US.
GE Healthcare has received exclusive global rights to market the VRIICU for use in emergency and operating rooms. DeepBreeze’s Vibration Response Imaging (VRI) monitors the breathing of patients on artificial respirators. The US Food and Drug Administration (FDA) recently approved the basic technology. However, more regulatory permits will be needed for the VRIICU before it can be sold in the US, and the companies expect a US launch in January.
DeepBreeze has a second VRI device for pulmonary imaging at clinics, which it plans to market independently.
DeepBreeze president and CEO Dr. Igal Kushnir says that GE Healthcare controls about 80% of the market for artificial respirators for operating theaters and 15-20% of the market for respirators for ICUs. The company’s VRI device is suitable for all type of artificial respirators.
Published by Globes [online], Israel business news - www.globes.co.il - on October 8, 2007
© Copyright of Globes Publisher Itonut (1983) Ltd. 2007
- Tel Aviv market report
- Tel Aviv Stock Exchange
- Israeli stocks in NY
- Arbitrage gaps for dual-listed stocks
- Israeli stocks in Europe
- Israeli stocks on other markets
- Tel Aviv 25 options
- Mutual funds
- Current representative shekel rates
- Historical representative shekel rates
- Bank shekel rates
- Shekel/dollar options